In August of 2023, the Foundation for Sarcoidosis Research (FSR) submitted a Request for Opinion Letter on Clinical Trials and the Family and Medical Leave Act (FMLA) with the U.S. Department of Labor (DOL).  On November 8, 2024, FSR received a letter of clarification from the DOL that ensures employee access to FMLA benefits when participating…